---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-272282"
form_type: "8-K"
ticker: "EVMN"
cik: "0002044725"
company_name: "Evommune, Inc."
filed_at: "2025-11-07T23:59:59+00:00"
generated_at: "2026-05-16T23:12:34.808766+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Evommune amends charter and bylaws upon IPO closing on Nov 7, 2025

## Summary
- Filed amended and restated certificate of incorporation with Delaware Secretary of State on November 7, 2025.
- Adopted amended and restated bylaws effective immediately prior to IPO closing, as pre-approved by board and stockholders.
- IPO closed on November 7, 2025; amendments are standard governance updates for a public company.
- Company is an emerging growth company trading on NYSE under symbol EVMN.

## SEC filing metadata
- accession: 0001193125-25-272282
- form_type: 8-K
- ticker: EVMN
- cik: 0002044725
- company_name: Evommune, Inc.
- filed_at: 2025-11-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2044725/000119312525272282/0001193125-25-272282-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2044725/000119312525272282/d38367d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-272282
- JSON: https://secwatch.observer/filing/0001193125-25-272282.json
- Plain text: https://secwatch.observer/filing/0001193125-25-272282.txt

## Key facts
- Governance Changes
  Evommune, Inc.: Amended and restated certificate of incorporation filed in connection with IPO (effective 2025-11-07).
  - Change: charter amendment
  - Effective: 2025-11-07
  source text: the Company filed an amended and restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware. The Company’s board of directors (the “Board”) and stockholders previously approved the Restated Certificate to be effective as of immediately prior to the closing of the IPO.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2044725/000119312525272282/0001193125-25-272282-index.htm
- Governance Changes
  Evommune, Inc.: Amended and restated bylaws adopted in connection with IPO (effective 2025-11-07).
  - Change: bylaw amendment
  - Effective: 2025-11-07
  source text: Effective as of November 7, 2025, the Company adopted amended and restated bylaws (the “Restated Bylaws”) in connection with the closing of the IPO.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2044725/000119312525272282/0001193125-25-272282-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.